Table 3.
Characteristics | TotalN = 153 | coNLR‐PLR | P value | ||
---|---|---|---|---|---|
Score 0 | Score 1 | Score 2 | |||
Age (y) | |||||
<60 | 64 | 17 | 32 | 15 | .467 |
≥60 | 89 | 21 | 39 | 29 | |
Sex | |||||
Female | 72 | 17 | 36 | 19 | .695 |
Male | 81 | 21 | 35 | 25 | |
Location | |||||
Colon | 61 | 14 | 26 | 21 | .451 |
Rectal | 92 | 24 | 45 | 23 | |
Tumor size (cm) | |||||
<5 | 63 | 16 | 23 | 24 | .063 |
≥5 | 90 | 22 | 48 | 20 | |
Cancer stage | |||||
II | 51 | 22 | 18 | 10 | .001 |
III‐IV | 102 | 16 | 53 | 34 | |
Cancer grade | |||||
G1/G2 | 99 | 21 | 51 | 27 | .194 |
G3/G4 | 54 | 17 | 20 | 17 | |
Tumor invasion | |||||
T1/T2 | 66 | 24 | 23 | 19 | .008 |
T3/T4 | 87 | 14 | 48 | 25 | |
Lymph node | |||||
N0 | 79 | 27 | 36 | 16 | .007 |
N+ | 74 | 11 | 35 | 28 | |
NLR | |||||
<2.24 | 68 | 29 | 26 | 13 | <.001 |
≥2.24 | 85 | 9 | 45 | 31 | |
PLR | |||||
<186 | 74 | 24 | 34 | 16 | <.001 |
≥186 | 79 | 14 | 37 | 28 |
CoNLR‐PLR, combined neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio.